Fidelity Investments
MCRB icon

Fidelity Investments’s Seres Therapeutics MCRB Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$2.99M Sell
268,704
-21,620,728
-99% -$240M ﹤0.01% 2346
2025
Q1
$15.3M Buy
21,889,432
+77,735
+0.4% +$54.4K ﹤0.01% 1770
2024
Q4
$18.1M Sell
21,811,697
-1,045,563
-5% -$869K ﹤0.01% 1761
2024
Q3
$21.6M Buy
22,857,260
+140,096
+0.6% +$133K ﹤0.01% 1683
2024
Q2
$16.4M Buy
22,717,164
+65,745
+0.3% +$47.6K ﹤0.01% 1712
2024
Q1
$17.5M Buy
22,651,419
+3,262,839
+17% +$2.53M ﹤0.01% 1701
2023
Q4
$27.1M Buy
19,388,580
+157,888
+0.8% +$221K ﹤0.01% 1510
2023
Q3
$45.8M Buy
19,230,692
+45,484
+0.2% +$108K ﹤0.01% 1273
2023
Q2
$91.9M Buy
19,185,208
+273,750
+1% +$1.31M 0.01% 1031
2023
Q1
$107M Buy
18,911,458
+222,697
+1% +$1.26M 0.01% 953
2022
Q4
$105M Buy
18,688,761
+78,028
+0.4% +$437K 0.01% 953
2022
Q3
$119M Buy
18,610,733
+9,521
+0.1% +$61.1K 0.01% 894
2022
Q2
$63.8M Buy
18,601,212
+4,723,347
+34% +$16.2M 0.01% 1155
2022
Q1
$98.8M Buy
13,877,865
+100,795
+0.7% +$718K 0.01% 1066
2021
Q4
$115M Buy
13,777,070
+19,285
+0.1% +$161K 0.01% 1042
2021
Q3
$95.8M Buy
13,757,785
+838,712
+6% +$5.84M 0.01% 1123
2021
Q2
$308M Buy
12,919,073
+638,400
+5% +$15.2M 0.02% 643
2021
Q1
$253M Buy
12,280,673
+944,100
+8% +$19.4M 0.02% 683
2020
Q4
$278M Buy
11,336,573
+619,173
+6% +$15.2M 0.02% 613
2020
Q3
$303M Buy
10,717,400
+4,975,324
+87% +$141M 0.03% 470
2020
Q2
$27.3M Sell
5,742,076
-407,670
-7% -$1.94M ﹤0.01% 1425
2020
Q1
$22M Sell
6,149,746
-349,372
-5% -$1.25M ﹤0.01% 1364
2019
Q4
$22.4M Sell
6,499,118
-649,728
-9% -$2.24M ﹤0.01% 1552
2019
Q3
$28.7M Sell
7,148,846
-953,100
-12% -$3.82M ﹤0.01% 1431
2019
Q2
$26.1M Buy
8,101,946
+2,279,801
+39% +$7.34M ﹤0.01% 1516
2019
Q1
$40M Sell
5,822,145
-306,241
-5% -$2.1M ﹤0.01% 1303
2018
Q4
$27.7M Buy
6,128,386
+9,037
+0.1% +$40.8K ﹤0.01% 1424
2018
Q3
$46.4M Buy
6,119,349
+23,749
+0.4% +$180K 0.01% 1307
2018
Q2
$52.4M Buy
6,095,600
+647
+0% +$5.56K 0.01% 1257
2018
Q1
$44.7M Buy
6,094,953
+17,732
+0.3% +$130K 0.01% 1348
2017
Q4
$61.6M Buy
6,077,221
+2,625
+0% +$26.6K 0.01% 1200
2017
Q3
$97.4M Buy
6,074,596
+18,302
+0.3% +$294K 0.01% 985
2017
Q2
$68.4M Buy
6,056,294
+3,375
+0.1% +$38.1K 0.01% 1148
2017
Q1
$68.2M Buy
6,052,919
+1,856
+0% +$20.9K 0.01% 1149
2016
Q4
$59.9M Buy
6,051,063
+12,188
+0.2% +$121K 0.01% 1214
2016
Q3
$74.2M Buy
6,038,875
+110,899
+2% +$1.36M 0.01% 1122
2016
Q2
$172M Buy
5,927,976
+49,924
+0.8% +$1.45M 0.02% 735
2016
Q1
$156M Buy
5,878,052
+19,687
+0.3% +$523K 0.02% 771
2015
Q4
$206M Buy
5,858,365
+13,819
+0.2% +$485K 0.03% 644
2015
Q3
$173M Buy
5,844,546
+606,081
+12% +$18M 0.02% 701
2015
Q2
$217M Buy
+5,238,465
New +$217M 0.03% 656